{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:40Z","timestamp":1786982380484,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12328-023-01799-6","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T12:02:56Z","timestamp":1681128176000},"page":"527-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy of dupilumab in induction and maintenance of remission in an adult patient with steroid-dependent eosinophilic enteritis (EoN)"],"prefix":"10.1007","volume":"16","author":[{"given":"Sho","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misugi","family":"Uga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunehito","family":"Yauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"1799_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/18756336MTAxdNzcpx","volume":"16","author":"A Licari","year":"2020","unstructured":"Licari A, Votto M, D\u2019Auria E, et al. Eosinophilic gastrointestinal diseases in children: a practical review. Curr Pediatr Rev. 2020;16:106\u201314.","journal-title":"Curr Pediatr Rev"},{"key":"1799_CR2","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.cgh.2022.02.017","volume":"20","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Gonsalves N, Abonia JP, et al. International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. Clin Gastroenterol Hepatol. 2022;20:2474-84.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1799_CR3","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","volume":"15","author":"E Mansoor","year":"2017","unstructured":"Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15:1733\u201341.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1799_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.cgh.2011.07.017","volume":"9","author":"G Pineton de Chambrun","year":"2011","unstructured":"Pineton de Chambrun G, Gonzalez F, Canva JY, et al. Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol. 2011;9:950-6.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1799_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11894-021-00809-2","volume":"23","author":"PH Chen","year":"2021","unstructured":"Chen PH, Anderson L, Zhang K, et al. Eosinophilic gastritis\/gastroenteritis. Curr Gastroenterol Rep. 2021;23:13.","journal-title":"Curr Gastroenterol Rep"},{"key":"1799_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MPG.0000000000003512","volume":"75","author":"N Patel","year":"2022","unstructured":"Patel N, Goyal A, Thaker A, et al. A case series on the use of dupilumab for treatment of refractory eosinophilic gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2022;75:192\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1799_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.13463","volume":"32","author":"M Zhang","year":"2017","unstructured":"Zhang M, Li Y. Eosinophilic gastroenteritis: a state-of-the-art review. J Gastroenterol Hepatol. 2017;32:64\u201372.","journal-title":"J Gastroenterol Hepatol"},{"key":"1799_CR8","first-page":"183","volume":"18","author":"C Anuradha","year":"2012","unstructured":"Anuradha C, Mittal R, Yacob M, et al. Eosinophilic disorders of the gastrointestinal tract: imaging features. Diagn Interv Radiol. 2012;18:183\u20138.","journal-title":"Diagn Interv Radiol"},{"key":"1799_CR9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3109\/00365521.2011.579998","volume":"46","author":"L Zhang","year":"2011","unstructured":"Zhang L, Duan L, Ding S, et al. Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol. 2011;46:1074\u201380.","journal-title":"Scand J Gastroenterol"},{"key":"1799_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1365-2036.2009.03937.x","volume":"29","author":"MM Walker","year":"2009","unstructured":"Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765\u201373.","journal-title":"Aliment Pharmacol Ther"},{"key":"1799_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/gutjnl-2012-303857","volume":"63","author":"H Vanheel","year":"2014","unstructured":"Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63:262\u201371.","journal-title":"Gut"},{"key":"1799_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00042737-200104000-00021","volume":"13","author":"AC Tan","year":"2001","unstructured":"Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol. 2001;13:425\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1799_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.dld.2005.06.013","volume":"38","author":"E Siewert","year":"2006","unstructured":"Siewert E, Lammert F, Koppitz P, et al. Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide. Dig Liver Dis. 2006;38:55\u20139.","journal-title":"Dig Liver Dis"},{"key":"1799_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00005176-200403000-00021","volume":"38","author":"CA Friesen","year":"2004","unstructured":"Friesen CA, Kearns GL, Andre L, et al. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr. 2004;38:343\u201351.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1799_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1023\/A:1010682310928","volume":"46","author":"DA Schwartz","year":"2001","unstructured":"Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001;46:1787\u201390.","journal-title":"Dig Dis Sci"},{"key":"1799_CR16","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.3748\/wjg.15.2156","volume":"15","author":"RA Sheikh","year":"2009","unstructured":"Sheikh RA, Prindiville TP, Pecha RE, et al. Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol. 2009;15:2156\u201361.","journal-title":"World J Gastroenterol"},{"key":"1799_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12016-019-08732-1","volume":"57","author":"N Gonsalves","year":"2019","unstructured":"Gonsalves N. Eosinophilic gastrointestinal disorders. Clin Rev Allergy Immunol. 2019;57:272\u201385.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1799_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","volume":"145","author":"T Shoda","year":"2020","unstructured":"Shoda T, Wen T, Caldwell JM, et al. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. J Allergy Clin Immunol. 2020;145:255\u201369.","journal-title":"J Allergy Clin Immunol"},{"key":"1799_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.anai.2019.11.018","volume":"124","author":"RD Pesek","year":"2020","unstructured":"Pesek RD, Gupta SK. Future therapies for eosinophilic gastrointestinal disorders. Ann Allergy Asthma Immunol. 2020;124:219\u201326.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1799_CR20","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","volume":"387","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med. 2022;387:2317\u201330.","journal-title":"N Engl J Med"},{"key":"1799_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S2213-2600(21)00322-2","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, Ford LB, Maspero JF, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2022;10:11\u201325.","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01799-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T14:35:45Z","timestamp":1689777345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01799-6","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The administration of budesonide and dupilumab to this EoN patient with severe asthma was done after obtaining the approval of the ethics review committee of Soka municipal hospital and the informed consent of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was given by the patient for the publication of this manuscript. Identifying information, aside from age and sex, was removed and the images provided were anonymized to protect patient confidentiality.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}